A Pilot Study to Evaluate the Safety and Efficacy of Mycophenolate Sodium (Myfortic) in Combination With Sirolimus (Rapamune) in Stable Renal Allograft Recipients.

Trial Profile

A Pilot Study to Evaluate the Safety and Efficacy of Mycophenolate Sodium (Myfortic) in Combination With Sirolimus (Rapamune) in Stable Renal Allograft Recipients.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 30 Jun 2011

At a glance

  • Drugs Mycophenolate sodium; Sirolimus; Tacrolimus
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Acronyms MYFIIRP
  • Most Recent Events

    • 30 Jun 2011 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
    • 18 Sep 2009 Planned end date changed from 1 Dec 2008 to 1 Mar 2011 as reported by ClinicalTrials.gov.
    • 06 Aug 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top